tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoffrey Porges, 197 are a BUY (67.24%), 95 are a HOLD (32.42%), 1 are a SELL (0.34%).
Analyst Geoffrey Porges, carries an average stock price target met ratio of 61.57% that have a potential upside of 29.07% achieved within 378 days. Previously, Geoffrey Porges worked at BERNSTEIN, LEERINK.
Geoffrey Porges’s has documented 600 price targets and ratings displayed on 31 stocks. The coverage was on Healthcare, Basic Materials, Consumer Defensive sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 02-Mar-2026.
Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for TBPH (THERAVANCE BIOPHARMA) at 10/31/2016. The price target of $33 was fulfilled within 11 days with a profit of $7.87 (31.32%) receiving and performance score of 28.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$338
$46.69 (16.03%)
$282
9 days ago
(02-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 05-Feb-2020
$322
$30.69 (10.54%)
$288
9 days ago
(02-Nov-2026)
45/46 (97.83%)
$27.11 (9.19%)
407
Buy Since 08-Dec-2021
$340
$48.69 (16.71%)
$300
9 days ago
(02-Nov-2026)
10/13 (76.92%)
$45.11 (15.30%)
514
Buy Since 02-Nov-2026
$342
$50.69 (17.40%)
$206
9 days ago
(02-Nov-2026)
19/20 (95%)
$47.11 (15.98%)
376
Buy Since 25-Feb-2026
$330
$38.69 (13.28%)
$280
9 days ago
(02-Nov-2026)
7/8 (87.5%)
$35.11 (11.91%)
173
